Gain Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -21 | 4,874 | -22 | -2,722 |
EBITDA | -5,404 | -4,439 | -4,712 | -5,645 |
EBIT | -5,425 | -4,467 | -4,735 | -5,667 |
Net Income | -5,608 | -4,537 | -5,284 | -5,809 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,727 | -4,618 | -4,926 | -5,098 |
Cash | 16,539 | 20,837 | 8,807 | 6,694 |
Basic Shares | 42,230 | 32,968 | 34,998 | 30,341 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $55 | $140 |
Gross Profit | -94 | -84 | 55 | 140 |
EBITDA | -19,205 | -19,790 | -22,104 | -17,433 |
EBIT | -19,299 | -19,874 | -22,188 | -17,497 |
Net Income | -20,161 | -20,411 | -22,267 | -17,590 |
Net Change In Cash | 0 | 0 | 55 | 140 |
Cost of Revenue | -29,545 | |||
Free Cash Flow | -18,465 | -18,896 | -18,881 | -14,811 |
Cash | 20,837 | 10,385 | 11,794 | 7,311 |
Basic Shares | 32,968 | 22,881 | 13,011 | 11,883 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.13 |
2025-12-31 | -$0.11 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.19 |